H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency

被引:72
作者
Svotelis, Amy [1 ]
Bianco, Stephanie [1 ]
Madore, Jason [2 ]
Huppe, Gabrielle [1 ]
Nordell-Markovits, Alexei [1 ]
Mes-Masson, Anne-Marie [2 ]
Gevry, Nicolas [1 ]
机构
[1] Univ Sherbrooke, Dept Biol, Fac Sci, Sherbrooke, PQ J1K 2R1, Canada
[2] CR CHUM, Inst Canc Montreal, Montreal, PQ, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
BCL2; H3K27me3; JMJD3; oestrogen receptors; ESTROGEN-RECEPTOR-ALPHA; HISTONE METHYLTRANSFERASE ACTIVITY; POSITIVE BREAST-CANCER; ENDOCRINE RESISTANCE; TAMOXIFEN RESISTANCE; CELL-PROLIFERATION; EZH2; EXPRESSION; LYSINE-27; MECHANISMS;
D O I
10.1038/emboj.2011.284
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chromatin represents a repressive barrier to the process of ligand-dependent transcriptional activity of nuclear receptors. Here, we show that H3K27 methylation imposes ligand-dependent regulation of the oestrogen receptor a (ER alpha)-dependent apoptotic response via Bcl-2 in breast cancer cells. The activation of BCL2 transcription is dependent on the simultaneous inactivation of the H3K27 methyltransferase, EZH2, and the demethylation of H3K27 at a poised enhancer by the ER alpha-dependent recruitment of JMJD3 in hormone-dependent breast cancer cells. We also provide evidence that this pathway is modified in cells resistant to anti-oestrogen (AE), which constitutively express BCL2. We show that the lack of H3K27 methylation at BCL2 regulatory elements due to the inactivation of EZH2 by the HER2 pathway leads to this constitutive activation of BCL2 in these AE-resistant cells. Our results describe a mechanism in which the epigenetic state of chromatin affects ligand dependency during ER alpha-regulated gene expression. The EMBO Journal (2011) 30, 3947-3961. doi:10.1038/emboj.2011.284; Published online 12 August 2011
引用
收藏
页码:3947 / 3961
页数:15
相关论文
共 87 条
[1]   UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development [J].
Agger, Karl ;
Cloos, Paul A. C. ;
Christensen, Jesper ;
Pasini, Diego ;
Rose, Simon ;
Rappsilber, Juri ;
Issaeva, Irina ;
Canaani, Eli ;
Salcini, Anna Elisabetta ;
Helin, Kristian .
NATURE, 2007, 449 (7163) :731-U10
[2]   The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence [J].
Agger, Karl ;
Cloos, Paul A. C. ;
Rudkjaer, Lise ;
Williams, Kristine ;
Andersen, Gitte ;
Christensen, Jesper ;
Helin, Kristian .
GENES & DEVELOPMENT, 2009, 23 (10) :1171-1176
[3]   The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma [J].
Anderton, J. A. ;
Bose, S. ;
Vockerodt, M. ;
Vrzalikova, K. ;
Wei, W. ;
Kuo, M. ;
Helin, K. ;
Christensen, J. ;
Rowe, M. ;
Murray, P. G. ;
Woodman, C. B. .
ONCOGENE, 2011, 30 (17) :2037-2043
[4]   The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases [J].
Arold, ST ;
Ulmer, TS ;
Mulhern, TD ;
Werner, JM ;
Ladbury, JE ;
Campbell, ID ;
Noble, MEM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17199-17205
[5]   Chromatin signatures of pluripotent cell lines [J].
Azuara, V ;
Perry, P ;
Sauer, S ;
Spivakov, M ;
Jorgensen, HF ;
John, RM ;
Gouti, M ;
Casanova, M ;
Warnes, G ;
Merkenschlager, M ;
Fisher, AG .
NATURE CELL BIOLOGY, 2006, 8 (05) :532-U189
[6]   EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast [J].
Bachmann, IM ;
Halvorsen, OJ ;
Collett, K ;
Stefansson, IM ;
Straume, O ;
Haukaas, SA ;
Salvesen, HB ;
Otte, AP ;
Akslen, LA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) :268-273
[7]   Tamoxifen resistance and epigenetic modifications in breast cancer cell lines [J].
Badia, Eric ;
Oliva, Joan ;
Balaguer, Patrick ;
Cavailles, Vincent .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (28) :3035-3043
[8]   Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications [J].
Badve, S. ;
Nakshatri, H. .
JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (01) :6-12
[9]   Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS [J].
Barradas, Marta ;
Anderton, Emma ;
Acosta, Juan Carlos ;
Li, SiDe ;
Banito, Ana ;
Rodriguez-Niedenfuehr, Marc ;
Maertens, Goedele ;
Banck, Michaela ;
Zhou, Ming-Ming ;
Walsh, Martin J. ;
Peters, Gordon ;
Gil, Jesus .
GENES & DEVELOPMENT, 2009, 23 (10) :1177-1182
[10]   Histone H3K4 demethylases are essential in development and differentiation [J].
Benevolenskaya, Elizaveta V. .
BIOCHEMISTRY AND CELL BIOLOGY, 2007, 85 (04) :435-443